We are proud to have supported EverImmune in its series A funding, enabling its lead product, Oncobax® AK, to enter the clinical stage in microbiota immuno-oncology

AEC Partners is proud to have supported Valbiotis with its estimated sizing of the mild to moderate hypertension market.